ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Approves Pembrolizumab for Esophageal or GEJ Carcinoma
March 26, 2021The U.S. Food and Drug Administration (FDA) approved pembrolizumab (Keytruda, Merck Sharp & Dohme Corp.) in combination with platinum and fluoropyrimidine-based chemotherapy for patients with metastatic or locally advanced esophageal or ... -
Senhwa Biosciences Presents Positive Cholangiocarcinoma Data
January 18, 2021Senhwa Biosciences, Inc., a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, announces that promising clinical data from their global phase 1b/2 trial, evaluating ... -
NIH study finds clues about why common cancer drug causes hearing loss
December 22, 2017Researchers find target to protect hearing during chemotherapy treatment
Pharma Sources Insight January 2025
